Study protocol for the Treating Opioid Patients' Pain and Sadness (TOPPS) study — A randomized control trial to lower depression and chronic pain interference, and increase care retention among persons receiving buprenorphine
Contemporary Clinical Trials · 2024
DOI: 10.1016/j.cct.2024.107608 ↗Kurz gefasst
Studienprotokoll in der Zeitschrift Contemporary Clinical Trials, 2024. Verfasst von Michael D Stein und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Law, Policy & Management, Boston University School of Public Health, 715 Albany Street, Boston, MA 02118, USA; Department of Psy…. Hauptthemen laut MEDLINE: Analgesics, Opioid, Buprenorphine, Chronic Pain, Depression. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: NIDA NIH HHS, National Institutes of Health, National Institute on Drug Abuse.
Themen: Schmerzmanagement, Depression
Abstract (Originalsprache)
BACKGROUND: Persons receiving prescription buprenorphine for opioid use disorder experience high rates of comorbid conditions such as chronic pain and depression, which present barriers to buprenorphine care retention. This paper describes the protocol of the TOPPS (Treating Opioid Patients' Pain and Sadness) study, which compares a values-based, behavioral activation intervention with a health education contact-control condition, with the aim of decreasing chronic pain and depression, and increasing buprenorphine care retention for persons with opioid use disorder. METHODS: This randomized controlled trial (RCT) enrolls and randomizes up to 250 participants currently being treated with buprenorphine to receive three months of either TOPPS, a six-session phone-based behavioral intervention, or a health education (HE) control condition. We compare the TOPPS intervention to HE on the following outcomes: 1) pain interference and pain severity over the 3-month treatment phrase; 2) depressive symptoms over the 3-month treatment phase; and 3) sustained improvements in pain interference, depressive symptoms, and buprenorphine treatment retention over the 12-month study period. We also examine mechanisms by which the intervention may reduce pain interference. DISCUSSION: This RCT explores a novel intervention to address chronic pain and depression for individuals receiving buprenorphine in office-based settings. TOPPS may lead to improved pain, depression, and substance use outcomes, and can utilize providers available within buprenorphine programs, broadening the disseminability of this intervention and heightening its public health impact. CLINICAL TRIAL: #NCT03698669.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Health Law, Policy & Management, Boston University School of Public Health, 715 Albany Street, Boston, MA 02118, USA; Department of Psychiatry and Human Behavior, Alpert Medical School of Brown University,…
- Department of Medicine, Section of General Internal Medicine, Boston Medical Center, Clinical Addiction Research and Education (CARE) Unit, 801 Massachusetts Avenue, 2nd Floor, Boston, MA 02118, USA. Electronic address:…
- Department of Health Law, Policy & Management, Boston University School of Public Health, 715 Albany Street, Boston, MA 02118, USA. Electronic address: skylarak@bu.edu.
- Department of Health Law, Policy & Management, Boston University School of Public Health, 715 Albany Street, Boston, MA 02118, USA. Electronic address: cmpierce@bu.edu.
- Department of Behavioral Medicine and Addictions Research, Butler Hospital, 345 Blackstone Blvd, Providence, RI 02906, USA.
- Department of Health Law, Policy & Management, Boston University School of Public Health, 715 Albany Street, Boston, MA 02118, USA. Electronic address: adunn@butler.org.
Förderung
- NIDA NIH HHS
- National Institutes of Health
- National Institute on Drug Abuse
Zitieren
APA
Stein, M. D., Bendiks, S., Karzhevsky, S., Pierce, C., Dunn, A., Majeski, A., Herman, D. S., & Weisberg, R. B. (2024). Study protocol for the Treating Opioid Patients' Pain and Sadness (TOPPS) study — A randomized control trial to lower depression and chronic pain interference, and increase care retention among persons receiving buprenorphine. Contemporary Clinical Trials. https://doi.org/10.1016/j.cct.2024.107608
Vancouver
Stein MD, Bendiks S, Karzhevsky S, Pierce C, Dunn A, Majeski A, et al. Study protocol for the Treating Opioid Patients' Pain and Sadness (TOPPS) study — A randomized control trial to lower depression and chronic pain interference, and increase care retention among persons receiving buprenorphine. Contemporary Clinical Trials. 2024. doi:10.1016/j.cct.2024.107608
BibTeX
@article{Stein2024,
author = {Stein, Michael D and Bendiks, Sally and Karzhevsky, Skylar and Pierce, Claire and Dunn, Ana and Majeski, Adam and Herman, Debra S and Weisberg, Risa B},
title = {Study protocol for the Treating Opioid Patients' Pain and Sadness (TOPPS) study — A randomized control trial to lower depression and chronic pain interference, and increase care retention among persons receiving buprenorphine},
journal = {Contemporary Clinical Trials},
year = {2024},
doi = {10.1016/j.cct.2024.107608}
}
EUVIMED